Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2011 Jan–Mar;25(1):49–57. doi: 10.1097/WAD.0b013e3181f333d6

Table 1.

Baseline characteristics of study population stratified by cognitive status (n=38).

MCI (n=19) NIE (n=19) Sig. level

Age, y, (SD) 73 (9) 75 (6) .39
Male, (%) 13 (68) 6 (32) .02*
Body Mass Index 27 (3) 26 (5) .48
Physical Activity Scale in Elderly 155 (70) 125 (47) .15
Blood pressure, Systolic 121 (16) 126 (15) .31
Blood pressure, Diastolic 63 (11) 63 (8) 1.0
APOE-ε4 carrier, (%) 8 (42) 5 (26) .32
Albumin, serum, g/dL 4.0 (0.3) 3.9 (0.3) .18
Creatinine, serum, g/dL 1.0 (0.2) 1.0 (0.2) .50
Homocysteine, plasma, μmol/L 8.6 (2.5) 8.6 (2.5) .96
Cholesterol, plasma, mg/dL 188 (32) 201 (32) .05
Calories consumed, total kCal 1549 (566) 1679 (505) .46
Mini Mental State Exam 26 (2.0) 29 (1.0) <.001*
Neurobehavioral Cognitive Status Exam, Total 69 (5) 77 (2) <.001*
Clinical Dementia Rating .35 (0.2) .0 (0.0) <.001*
WMS-R, Delayed Paragraph Recall 5 (6) 12 (5) .01*
Geriatric Depression Scale 2 (1) 1 (2) .54
Hachinski Ischemia Score 1 (1) 1 (0) .08
Acetylcholine esterase inhibitor use, (%) 74 0 <.001*
Statin use, (%) 63 11 <.001*
Multivitamin use, (%) 58 68 .51

MCI, amnestic – Mild Cognitive Impairment; NIE, Non-impaired elders

Mean and SD unless labeled otherwise,

*

Significance level set at P ≤ .05

Multivitamin use derived by interview with subject (and collateral historian for MCI), including examination of all bottles from which subject was regularly taking pills; WMS-R, Wechsler Memory Scale – Revised